(Q75447928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

title

Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference

1 reference

placebo-controlled trial

1 reference

1 reference

J K Kaukua

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

T A Pekkarinen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

A M Rissanen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

page(s)

600-605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

Obesity and health-related quality of life

18 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Relationships between body mass index and well-being in young Australian women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Assessing Impact of Weight on Quality of Life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Construct validity of the Impact of Weight on Quality of Life Questionnaire

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Impact of weight loss on health-related quality of life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

The psychological ramifications of weight management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Quality of life in NIDDM patients assessed with the SF-20 questionnaire.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Quality of life and associated characteristics in a large national sample of adults with diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

The evaluation of two measures of quality of life in patients with type I and type II diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Dimensions of quality of life in people with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Problems with the performance of the SF-36 among people with type 2 diabetes in general practice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Sibutramine. A review of its contribution to the management of obesity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Role of sibutramine in the treatment of obese Type 2 diabetic patients receiving sulphonylurea therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

The RAND 36-Item Health Survey 1.0.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Obesity and physical and emotional well-being: associations between body mass index, chronic illness, and the physical and mental components of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Psychological correlates of obesity: moving to the next research generation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Pain in the obese: impact on health-related quality-of-life.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802591

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802591

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14770192%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference